Table 3.
Antimicrobial agent class | Total |
Systemic |
Topical |
|||
---|---|---|---|---|---|---|
% | 95% CIa | % | 95% CIa | % | 95% CIa | |
Aminoglycoside | 12.0 | 11.4–12.6 | 0.1 | 0.0–0.2 | 29.1 | 28.0–30.2 |
Amphenicol | 1.9 | 1.6–2.1 | 0.0 | <0.00 | 4.5 | 3.9–5.2 |
Other antimicrobial agentb | 7.2 | 6.6–7.8 | 0.0 | <0.00 | 17.4 | 16.1–18.8 |
β-lactam | 43.6 | 42.3–44.8 | 73.8 | 72.2–75.4 | 0.1 | 0.0–0.2 |
Fluoroquinolone | 4.4 | 3.6–5.1 | 4.1 | 3.1–5.2 | 4.6 | 4.0–5.2 |
Fusidic acid | 18.2 | 17.4–19.0 | 0.0 | <0.00 | 44.3 | 43.1–45.4 |
Lincosamide | 4.7 | 4.2–5.2 | 7.9 | 7.0–8.8 | 0.0 | <0.00 |
Macrolide | 0.2 | 0.0–0.3 | 0.3 | 0.0–0.6 | 0.0 | <0.00 |
Nitroimidazole | 4.7 | 4.0–5.4 | 8.0 | 6.7–9.2 | 0.0 | <0.00 |
Nitroimidazole-macrolide | 0.8 | 0.5–1.0 | 1.3 | 0.8–1.7 | 0.0 | <0.00 |
Rifamycin | 0.0 | <0.00 | 0.0 | <0.00 | 0.0 | <0.00 |
Sulphonamide | 1.5 | 1.1–1.9 | 2.5 | 1.9–3.2 | 0.0 | <0.00 |
Tetracycline | 1.2 | 1.0–1.3 | 2.0 | 1.7–2.2 | 0.0 | 0.00–0.01 |
95% Confidence interval.
Consists of polymyxin b sulphate; mupirocin; novobiocin; thymol and bronopol.